Free Trial

Amgen (AMGN) SEC Filings & 10K Form

Amgen logo
$281.22 -2.56 (-0.90%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$281.11 -0.11 (-0.04%)
As of 05/2/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Amgen SEC Filings

DateFilerForm TypeView
04/17/2025
4:25 PM
Amgen (Filer)
Form DEFA14A
04/16/2025
11:44 AM
Amgen (Subject)
Chevedden John (Filed by)
Form PX14A6G
04/09/2025
7:35 AM
Amgen (Filer)
Form DEFA14A
04/09/2025
7:30 AM
Amgen (Filer)
Form DEF 14A
04/02/2025
8:00 AM
Amgen (Filer)
Form ARS
03/19/2025
7:17 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:18 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:19 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:20 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:21 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:22 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:22 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:14 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:15 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:16 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
6:58 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:05 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:06 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:06 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:07 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:08 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:09 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
6:55 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
6:56 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
6:57 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
7:06 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
7:07 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
3:27 PM
Amgen (Subject)
REESE DAVID M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2025
7:59 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
1:25 PM
Amgen (Subject)
Santos Esteban (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
8:02 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
2:01 PM
Amgen (Subject)
Gordon Murdo (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/10/2025
8:52 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:54 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
11:53 AM
Amgen (Subject)
Grygiel Nancy A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
3:05 PM
Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
5:17 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
6:48 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:37 PM
Amgen (Issuer)
Drake Michael V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:38 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:41 PM
Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Musk's warning signal: Prepare before the cascade begins (Ad)

When Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t. With 40+ years of market modeling, he says Musk’s move wasn’t about efficiency — it was a signal. And what’s coming next could divide the market into winners and losers faster than anyone expects. Watch this urgent video briefing now.

Watch the Musk market warning before the dominoes fall
11/06/2024
6:45 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:46 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
3:20 PM
Amgen (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13G/A
08/13/2024
4:44 PM
Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:41 PM
Amgen (Issuer)
Drake Michael V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:43 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
6:00 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
4:23 PM
Amgen (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/04/2024
6:26 PM
Amgen (Issuer)
ECKERT ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:27 PM
Amgen (Issuer)
Garland Greg C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:28 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:29 PM
Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:29 PM
Amgen (Issuer)
Jacks Tyler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:31 PM
Amgen (Issuer)
Klotman Mary E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:32 PM
Amgen (Issuer)
Kullman Ellen Jamison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:33 PM
Amgen (Issuer)
MILES AMY E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:22 PM
Amgen (Issuer)
Klotman Mary E. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/04/2024
6:23 PM
Amgen (Issuer)
Austin Wanda M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:24 PM
Amgen (Issuer)
Drake Michael V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:25 PM
Amgen (Issuer)
Druker Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
4:17 PM
Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
5:58 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
5:59 PM
Amgen (Issuer)
Bradner James E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:00 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:02 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:03 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:04 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:05 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:06 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:07 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:07 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:08 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:56 PM
Amgen (Issuer)
Drake Michael V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:57 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:58 PM
Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:30 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:31 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:32 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:33 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:34 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:35 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:36 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:36 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:37 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:39 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
7:23 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
7:24 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
7:25 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:48 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:17 PM
Amgen (Subject)
Grygiel Nancy A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Musk's warning signal: Prepare before the cascade begins (Ad)

When Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t. With 40+ years of market modeling, he says Musk’s move wasn’t about efficiency — it was a signal. And what’s coming next could divide the market into winners and losers faster than anyone expects. Watch this urgent video briefing now.

Watch the Musk market warning before the dominoes fall
05/03/2024
6:18 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:19 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:20 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:22 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:23 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:24 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:25 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
6:59 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
7:00 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AMGN) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners